Pharmaceutical

Sanofi invests $1.4bn in insulin production in Germany

Sanofi has announced a significant investment of €1.3bn ($1.4bn) to expand its insulin production capabilities in Frankfurt, Germany.

Aug 3, 2024 - 04:00
Sanofi invests $1.4bn in insulin production in Germany
Sanofi has announced a significant investment of €1.3bn ($1.4bn) to expand its insulin production capabilities in Frankfurt, Germany.
Read the original article

Tags:

Previous Article

Rejuvenate and SAS partner to harness AI for age-related diseases

Next Article

FDA expands GSK’s Jemperli approval for endometrial cancer

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Demand spikes in seniors, behavioral health care challenge UnitedHealth’s provider arm

STAT+: Demand spikes in seniors, behavioral health care...

Jul 14, 2023

Ambulance rides for just $100? Government advisers want major billing fixes

Ambulance rides for just $100? Government advisers want...

Nov 9, 2023

Wegovy can reduce heart failure symptoms in obese patients, study shows

Wegovy can reduce heart failure symptoms in obese patie...

Aug 26, 2023